l e t t e r s 2 86 VOLUME 18 | NUMBER 2 | FEBRUARY 2012 nature medicine Blood pressure regulation is crucial for the maintenance of health, and hypertension is a risk factor for myocardial infarction, heart failure, stroke and renal disease. Nitric oxide (NO) and prostacyclin trigger well-defined vasodilator pathways; however, substantial vasorelaxation in response to agents such as acetylcholine persists when the synthesis of these molecules is prevented. This remaining vasorelaxation activity, termed endothelium-derived hyperpolarizing factor (EDHF), is more prevalent in resistance than in conduit blood vessels and is considered a major mechanism for blood pressure control 1-4 . Hydrogen peroxide (H 2 O 2 ) has been shown to be a major component of EDHF in several vascular beds in multiple species, including in humans 5-10 . H 2 O 2 causes the formation of a disulfide bond between the two a subunits of protein kinase G I-a (PKGI-a), which activates the kinase independently of the NO-cyclic guanosine monophosphate (cGMP) pathway and is coupled to vasodilation 11 . To test the importance of PKGI-a oxidation in the EDHF mechanism and blood pressure control in vivo, we generated a knock-in mouse expressing only a C42S 'redox-dead' version of PKGI-a. This amino acid substitution, a single-atom change (an oxygen atom replacing a sulfur atom), blocked the vasodilatory action of H 2 O 2 on resistance vessels and resulted in hypertension in vivo.
Blood pressure regulation is crucial for the maintenance of health, and hypertension is a risk factor for myocardial infarction, heart failure, stroke and renal disease. Nitric oxide (NO) and prostacyclin trigger well-defined vasodilator pathways; however, substantial vasorelaxation in response to agents such as acetylcholine persists when the synthesis of these molecules is prevented. This remaining vasorelaxation activity, termed endothelium-derived hyperpolarizing factor (EDHF), is more prevalent in resistance than in conduit blood vessels and is considered a major mechanism for blood pressure control [1] [2] [3] [4] . Hydrogen peroxide (H 2 O 2 ) has been shown to be a major component of EDHF in several vascular beds in multiple species, including in humans [5] [6] [7] [8] [9] [10] . H 2 O 2 causes the formation of a disulfide bond between the two a subunits of protein kinase G I-a (PKGI-a), which activates the kinase independently of the NO-cyclic guanosine monophosphate (cGMP) pathway and is coupled to vasodilation 11 . To test the importance of PKGI-a oxidation in the EDHF mechanism and blood pressure control in vivo, we generated a knock-in mouse expressing only a C42S 'redox-dead' version of PKGI-a. This amino acid substitution, a single-atom change (an oxygen atom replacing a sulfur atom), blocked the vasodilatory action of H 2 O 2 on resistance vessels and resulted in hypertension in vivo.
Using site-directed mutagenesis, we engineered the Prkg1 gene so that the wild-type (WT) PKGI-α was systemically replaced with a C42S mutant, generating a 'redox-dead' knock-in mouse. We compared the vasorelaxation response of arteries from WT and knock-in mice to H 2 O 2 . There was a significant (P < 0.05) rightward shift (indicating insensitivity) in the dose-response curve of knock-in compared to WT mesenteric ( Fig. 1a ; half-maximal effective concentration (EC 50 ) WT = 23.7 ± 3.2 µM compared to (EC 50 ) KI = 79.4 ± 13.9 µM (means ± s.e.m.)), carotid, renal and femoral arteries ( Supplementary  Fig. 1a-c) . Knock-in aortas were partially resistant to H 2 O 2 -induced relaxation and showed a 45% deficit in maximal dilatory response at high doses of oxidant (Fig. 1b) . The initial force of contraction induced by various treatments did not differ between WT and knock-in aortas or mesenteric vessels ( Supplementary Table 1 ). Vessel size correlated with sensitivity to H 2 O 2 (Supplementary Fig. 1d) , with smaller vessels having a lower EC 50 for H 2 O 2 -dependent relaxation. As anticipated, H 2 O 2 treatment of WT mesenteric or aortic vessels induced PKGI-α disulfide bond formation, whereas this did not occur in knock-in vessels ( Fig. 1c) . Pharmacological inhibition of PKG activity using Rp-8-Br-PET-cGMP attenuated H 2 O 2 -induced vasorelaxation in WT mesenteric vessels ( Supplementary Fig. 2a ), although the shift in the relaxation curve caused by PKG inhibition was rather small. Interpretation of the effects of Rp-8-Br-PET-cGMP is not straightforward as its potency and selectivity can change depending on the precise molecular state of PKG, which is sensitive to the cellular redox state and to cGMP concentration, although disulfide-activated PKG is known to be inhibited by Rp-8-Br-PET-cGMP in vitro 12 Figs. 2b and 3b) , by inhibition of NO synthase with NG-nitro-l-arginine methyl ester (l-NAME), by inhibition of cyclooxygenase with indomethacin, or by combined treatment with l-NAME and indomethacin ( Supplementary Figs. 2c,d  and 3c,d) . These observations provide further support that H 2 O 2 directly activates PKGI-α to induce vasorelaxation. H 2 O 2 induced hyperpolarization of WT mesenteric vessels, which was attenuated by treatment with either of the potassium channel inhibitors apamin or charybdotoxin and was effectively blocked when the two agents were used together ( Fig. 1d) . Knock-in mesenteric vessels had a marked deficit in H 2 O 2 -induced hyperpolarization compared to WT vessels (Fig. 1d) . The observation that apamin-and charybdotoxin-sensitive potassium channels are integral to oxidantand EDHF-mediated vasorelaxation is consistent with results from other studies 4, [13] [14] [15] [16] . Disulfide-activated PKG could potentially phosphorylate such potassium channels to result in membrane hyperpolarization. The molecular basis of EDHF, and in particular the identity of the potassium channels involved, is controversial, as EDHF responses can be species, sex and vascular-bed dependent. Potential selectivity and specificity issues associated with potassium channel inhibitors add further complexity. Results from some other studies appear to be inconsistent with the scheme we have presented here.
For example, activation of endothelial SK3 and IK1 potassium channels has been reported to be required for EDHF-mediated responses, as is calcium-dependent activation of endothelial NO synthase 17 . However, the SK3 and IK1 potassium channels are considered to be at low abundance in healthy vascular smooth muscle cells, and their activation by PKG has not been described.
In addition, a number of BK Ca , ATP-sensitive and inwardly rectifying potassium channels have also been reported to induce the hyperpolarization of smooth muscle cells in response to H 2 O 2 . However, some of these channels or their accessory, regulatory proteins have their own redox-sensitive thiols that can directly respond to H 2 O 2 independently of PKG kinase activity 18 .
To establish whether PKGI-α disulfide activation contributes to EDHF activity, we compared vasorelaxation of WT and knock-in vessels in response to acetylcholine with or without combined NO synthase inhibition (using l-NAME , to block NO synthesis) and cyclooxygenase inhibition (using indomethacin, to block prostacyclin synthesis). This 'EDHF protocol' induced disulfide formation in WT but not knock-in mesenteric vessels ( Fig. 2a) . Acetylcholineinduced vasorelaxation was significantly (P < 0.05) deficient in knock-in mesenteric vessels compared to WT vessels ( Fig. 2a) . The acetylcholine-dependent relaxation of WT mesenteric vessels was substantially attenuated by treatment with l-NAME ( Fig. 2b; (EC 50 ) WT = 148.9 ± 48.9 nM compared to (EC 50 ) KI = 614.2 ± 162.9 nM) (means ± s.e.m.)), catalase (which decomposes H 2 O 2 ; Fig. 2c ), or the combination of l-NAME and catalase ( Supplementary Fig. 4f ). In addition, pharmacological blockade of PKG or removal of the endothelium substantially attenuated the acetylcholine-induced relaxation of WT mesenteric vessels ( Supplementary Fig. 4a,b) . In contrast, indomethacin alone did not alter acetylcholine-induced vasorelaxation ( Supplementary Fig. 4c ), whereas indomethacin combined with l-NAME partially blocked vasorelaxation (Supplementary Fig. 4d ) and the combination of indomethacin, catalase and l-NAME resulted in full blockade of vasorelaxation ( Supplementary Fig. 4e ). These observations are consistent with a model in which acetylcholine triggers two primary pathways leading to vasorelaxation in mesenteric resistance vessels, with one pathway leading to synthesis of NO and the other to synthesis of H 2 O 2 . The involvement of H 2 O 2 is consistent with a number of studies linking EDHF-dependent relaxation to the synthesis of H 2 O 2 (refs. 7,9,19) , which has been suggested to be derived from NO synthase-generated superoxide in resistance vessels 19 . Aortas from both WT and knock-in mice lacked an EDHF response ( Fig. 2d) , consistent with reports that this hyperpolarization mechanism is largely absent from conduit vessels 9 . An NO donor relaxed both conduit and resistance vessels in mice of both genotypes equally ( Supplementary Figs. 2a  and 5a,c) , as did the direct PKG activator 8-Br-cGMP ( Supplementary  Fig. 5b,d) . The equal levels of acetylcholine-induced relaxation in WT and knock-in aortas, as well as the observation that acetylcholineinduced relaxation of both WT and knock-in aortas were fully blocked by l-NAME ( Fig. 2e) and were insensitive to catalase ( Fig. 2f) , suggests that acetylcholine is unable to recruit the kinase oxidation pathway in the aorta. Furthermore, an EDHF protocol failed to induce PKGI-α disulfide formation in both WT and knockin aortas (Fig. 2d) . Acetylcholine-induced relaxation of the aorta was attenuated by PKG inhibition and was fully blocked by treatment with a combination of l-NAME, indomethacin and catalase, and this relaxation was also endothelium dependent ( Supplementary  Fig. 6a-d) . We conclude that acetylcholine-induced relaxation of aorta is through the classical NO-cGMP pathway and does not involve EDHF-induced oxidation of PKG.
Overall, our observations are consistent with EDHF being a property of resistance vessels that, at least in part, relies on a pathway that generates H 2 O 2 . We interpret the reduced ability of knock-in vessels to relax in response to an EDHF protocol as the result of the insensitivity of C42S PKGI-α to H 2 O 2 , thereby blocking transduction of the oxidant signal into kinase activity that normally couples vasorelaxation in resistance vessels. To assess the role of this disulfide oxidation pathway in blood pressure regulation in vivo, we monitored the blood pressures of WT and knock-in mice by telemetry. Mean, systolic and diastolic arterial pressures were significantly (P < 0.05) higher in knock-in mice than in WT littermate controls (Fig. 3a) . The blood pressures of both WT and knock-in mice increased at night as they become more active during the dark cycle, but the relative hypertension in knock-in compared to WT mice was maintained. Both WT and knock-in mice had increased blood pressure in response to treatment with l-NAME, but the magnitude of this increase was greater in knock-in compared to WT mice (Fig. 3b) . This result is consistent with the idea that PKGI-α disulfide activation during a hypertensive challenge normally enables blood pressure homeostasis. The small increase in blood pressure in knock-in mice caused by indomethacin treatment was greater than the increase observed in wild-type mice, but the responses were not significantly different (Fig. 3c) . These observations suggest that when NO-dependent vasorelaxation is compromised, the PKGI-α disulfideoxidation pathway may enable blood pressure homeostasis.
In contrast to these results, catalase-overexpressing mice have lowered blood pressure compared to controls, an effect that was reversed by treatment with a catalase inhibitor 20 . Similarly, catalase-overexpressing mice have a reduced pressor response to vasoconstrictors 21 . However, catalase may be ineffective at lowering the concentration of the cellular pool of H 2 O 2 that is pertinent to vasorelaxation, as this enzyme is mainly localized to peroxisomes. Catalase may thus not be able to compete with highly abundant, ubiquitously expressed peroxiredoxin proteins that have a K m of ~20 µM, approximating the EC 50 of WT mesenteric vessels for H 2 O 2 -dependent relaxation. These considerations may limit the conclusions made from studies of the effects of catalase overexpression. Furthermore, although catalase overexpression reduces the concentration of H 2 O 2 in some tissues, it does not have this effect in all tissues 20 , and the effects of catalase overexpression on the concentration of H 2 O 2 in resistance vessels were not studied 20 .
Although the hypertensive phenotype of the knock-in mouse can be explained by an intrinsic defect in the ability of their resistance blood vessels to sense, transduce and relax in response to H 2 O 2 , we also assessed several other factors that could potentially contribute to the hypertension of these mice. Using echocardiography, we found that the knock-in mice had a slightly depressed cardiac output compared to WT mice despite similar heart weights (Fig. 4a,b) , which may be an adaptive mechanism to limit hypertension. We observed no differences in blood vessel size or fibrosis (Fig. 4c,d) . Kidney function as assessed by plasma renin levels ( Fig. 4e) and inulin clearance (Fig. 4f ) was unaffected. We assessed possible central effects by monitoring heart rate variability and environmental stress responses as a noninvasive measure of autonomic function. We observed no differences in these metrics between WT and knock-in mice (Supplementary Fig. 7a,b) , implying that the hypertension of knock-in mice was not associated with a centrally mediated decrease in parasympathetic activity.
We conclude that PKGI-α disulfide formation is a key mechanism contributing to blood pressure homeostasis and is a major component of the EDHF phenomenon. Acetylcholine, in addition to triggering an NOdependent pathway, also recruits an H 2 O 2 -dependent mechanism that leads to oxidation and activation of PKG, which phosphorylates potassium channels to cause vessel hyperpolarization and relaxation. This regulatory mechanism operates basally to control blood pressure, such that elimination of this mechanism by the genetic removal of the thiol oxidant sensor in PKG results in hypertension. These observations are in contrast to the widely held view that oxidants are primarily harmful. Instead, our results support an evolving perspective of oxidants as crucial homeostatic regulators for the maintenance of health 22 .
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